AEM vs CE

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

Celanese Corporation exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating poor financial health. Despite a recent 1-year price recovery, the company is struggling with negative profit margins (-12.21%), a deeply negative ROE (-22.52%), and a high Debt/Equity ratio of 2.89. Revenue and earnings are in sharp decline, with YoY EPS growth collapsing by 88.3%. The disconnect between the bearish deterministic health scores and the 'Buy' analyst consensus suggests a speculative outlook rather than a fundamental one.